Skip to Content

Label Changes for:

Coly-Mycin M Parenteral Solution (colistimethate sodium, USP)

March 2013

Changes have been made to the WARNINGS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)


March 2013


  • Maximum daily dose calculated from colistin base activity should not exceed 5 mg/kg/day with normal renal function.